GL1X · GenesisL1 explorer

MolNFT v1 · #79439 · protein

Structure of HIV pr resistant patient derived mutant (comprising 22 mutations) in complex with drv

3T3C · HIV-1 protease: “Structure of HIV pr resistant patient derived mutant (comprising 22 mutations) in complex with drv”. X-ray diffraction, 2 ligands (017, SO4), 1 pocket (best druggability 0.68). MolNFT v1 #79439 on GenesisL1: 3D…

PDB
3T3C
Type
protein
Length
198 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
HIV-1 protease
EC
3.4.23.16
UniProt
P03367
Ligands
017, SO4
Pockets
1 · best druggability 0.68

Structure

x-ray diffraction · 1 distinct chain · 7% helix, 55% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BHIV-1 protease (EC 3.4.23.16)protein997% helix, 55% strandP03367

Ligands and binding sites

  • 017 · (3r,3as,6ar)-hexahydrofuro[2,3-b]furan-3-yl(1s,2r)-3-[[(4-aminophenyl)sulfonyl](isobutyl)amino]-1-benzyl-2-hydroxypropylcarbamate · ligand · chains A, B
  • SO4 · Sulfate ion · ion · 2 copies · chains A, B
  • BME · Beta-mercaptoethanol · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13850.680.8138017, SO4

Interfaces

1 interface between chains.

  • A–B · 1808 Ų buried · 32 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 covalent (additive adduct).

Compared structures

  • 3T3C · Structure of HIV PR resistant patient derived mutant (comprising 22 mutations) in complex… · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.